dpp 4 inhibitors and glp 1 agonists together Insights into the Roles of GLP-1, DPP-4, SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology The pharmacology of DPP-4 inhibitors

Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: a ran-domized, double-blind, placebo-controlled study

Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota

The easiest way to get exposure to this trend is with LLY and NVO, as their duopoly will maintain until at least 2027

Sonne and D

Towards tailored obesity treatment choices based on obesity-related complications Ectopic fat deposition in different organs results over time in progressive metabolic dysfunction and the development of organ-specific metabolic complications including T2D, MASLD/MASH and HFpEF [108]